As part of the collaboration, drugmaker will use Immunai’s AI model of the immune system and machine learning for clinical decision-making in drug discovery and development
The post Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials appeared first on The Times of Israel.
